ImmunityBio, Inc.
Hedge Funds Holdings
Last updated:
ImmunityBio, Inc.‘s stocks are currently a part of 111 hedge funds’ portfolios, which represents 7.95% of the total amount of its stocks outstanding. This makes up a total of 31.64M shares of ImmunityBio, Inc.. Compared to the previous quarter, the number fell by -4.43% or -1.46M shares fewer. As for the holding position changes, 43.24% (48) of current hedge fund investors increased the number of shares held, 19.82% (22) of current holders sold a part of the shares held, and 18.02% (20) closed the holdings completely. 15 hedge funds are new holders of ImmunityBio, Inc. stock in Q3 2022, it is 13.51% of total holders.
Hedge funds holding ImmunityBio (Q1 2019 – Q3 2022)
| Q1 2019 | 1 |
|---|---|
| Q2 2019 | 1 |
| Q3 2019 | 1 |
| Q4 2019 | 1 |
| Q1 2020 | 1 |
| Q2 2020 | 1 |
| Q3 2020 | 1 |
| Q4 2020 | 1 |
| Q1 2021 | 115 |
| Q2 2021 | 118 |
| Q3 2021 | 120 |
| Q4 2021 | 133 |
| Q1 2022 | 140 |
| Q2 2022 | 125 |
| Q3 2022 | 111 |
Hedge funds changes in ImmunityBio positions (Q1 2019 – Q3 2022)
| Q1 2019 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q2 2019 | 0 | 0 | 0 | 0 | 1 |
| Q3 2019 | 0 | 0 | 0 | 0 | 1 |
| Q4 2019 | 0 | 0 | 0 | 0 | 1 |
| Q1 2020 | 0 | 0 | 0 | 0 | 1 |
| Q2 2020 | 0 | 0 | 0 | 0 | 1 |
| Q3 2020 | 0 | 0 | 0 | 0 | 1 |
| Q4 2020 | 0 | 0 | 0 | 0 | 1 |
| Q1 2021 | 114 | 0 | 0 | 0 | 1 |
| Q2 2021 | 27 | 61 | 15 | 24 | -9 |
| Q3 2021 | 19 | 51 | 25 | 14 | 11 |
| Q4 2021 | 31 | 48 | 34 | 19 | 1 |
| Q1 2022 | 26 | 42 | 38 | 18 | 16 |
| Q2 2022 | 15 | 54 | 33 | 27 | -4 |
| Q3 2022 | 15 | 48 | 22 | 20 | 6 |
Hedge funds changes in ImmunityBio stock options (Q1 2019 – Q3 2022)
| Q1 2019 | 0 | 0 |
|---|---|---|
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 24,001,000 | 50,732,000 |
| Q2 2021 | 8,171,000 | 19,869,000 |
| Q3 2021 | 5,029,000 | 12,993,000 |
| Q4 2021 | 2,959,000 | 7,394,000 |
| Q1 2022 | 2,391,000 | 4,314,000 |
| Q2 2022 | 1,989,000 | 2,084,000 |
| Q3 2022 | 2,658,000 | 3,674,000 |